NEW YORK, Jan. 20, 2011 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the common stock of Molecular Insight Pharmaceuticals, Inc. Molecular Insight Pharmaceuticals, Inc.'s stock was suspended on December 21, 2010 and has not traded on NASDAQ since that time.
NASDAQ also announced that it will delist the common stock of Helicos BioSciences Corporation. Helicos BioSciences Corporation's stock was suspended on November 16, 2010 and has not traded on NASDAQ since that time.
NASDAQ also announced that it will delist the common stock of China INSOnline Corp. China INSOnline Corp.'s stock was suspended on November 24, 2010 and has not traded on NASDAQ since that time.
NASDAQ also announced that it will delist the common stock of Media Sciences International Inc. Media Sciences International Inc.'s stock was suspended on July 22, 2010 and has not traded on NASDAQ since that time.
NASDAQ also announced that it will delist the common stock of Angiotech Pharmaceuticals, Inc. Angiotech Pharmaceuticals, Inc.'s stock was suspended on January 13, 2011 and has not traded on NASDAQ since that time.
Finally, NASDAQ announced that it will delist the common stock of ICOP Digital, Inc. ICOP Digital, Inc.'s stock was suspended on January 13, 2011 and has not traded on NASDAQ since that time.
NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.
For more information about The NASDAQ Stock Market, visit the NASDAQ Web site at http://www.nasdaq.com. NASDAQ's rules governing the delisting of securities can be found in the NASDAQ Rule 5800 Series, available on the NASDAQ Web site: .
